
WSI based prediction of TP53 mutations identifies aggressive disease phenotype in prostate cancer
- Author
- Marija Pizurica (UGent) , Maarten Larmuseau (UGent) , Kim Van der Eecken, Louise de Schaetzen van Brienen (UGent) , Francisco Carrillo-Perez, Simon Isphording, Nicolaas Lumen (UGent) , Jo Van Dorpe (UGent) , Piet Ost (UGent) , Sofie Verbeke (UGent) , Olivier Gevaert and Kathleen Marchal (UGent)
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01HY0E617HN63BNTH94W375BVT
- MLA
- Pizurica, Marija, et al. “WSI Based Prediction of TP53 Mutations Identifies Aggressive Disease Phenotype in Prostate Cancer.” CANCER RESEARCH, vol. 83, no. 8, Supplement S, 2023, doi:10.1158/1538-7445.AM2023-LB171.
- APA
- Pizurica, M., Larmuseau, M., Van der Eecken, K., de Schaetzen van Brienen, L., Carrillo-Perez, F., Isphording, S., … Marchal, K. (2023). WSI based prediction of TP53 mutations identifies aggressive disease phenotype in prostate cancer. CANCER RESEARCH, 83(8, Supplement S). https://doi.org/10.1158/1538-7445.AM2023-LB171
- Chicago author-date
- Pizurica, Marija, Maarten Larmuseau, Kim Van der Eecken, Louise de Schaetzen van Brienen, Francisco Carrillo-Perez, Simon Isphording, Nicolaas Lumen, et al. 2023. “WSI Based Prediction of TP53 Mutations Identifies Aggressive Disease Phenotype in Prostate Cancer.” In CANCER RESEARCH. Vol. 83. https://doi.org/10.1158/1538-7445.AM2023-LB171.
- Chicago author-date (all authors)
- Pizurica, Marija, Maarten Larmuseau, Kim Van der Eecken, Louise de Schaetzen van Brienen, Francisco Carrillo-Perez, Simon Isphording, Nicolaas Lumen, Jo Van Dorpe, Piet Ost, Sofie Verbeke, Olivier Gevaert, and Kathleen Marchal. 2023. “WSI Based Prediction of TP53 Mutations Identifies Aggressive Disease Phenotype in Prostate Cancer.” In CANCER RESEARCH. Vol. 83. doi:10.1158/1538-7445.AM2023-LB171.
- Vancouver
- 1.Pizurica M, Larmuseau M, Van der Eecken K, de Schaetzen van Brienen L, Carrillo-Perez F, Isphording S, et al. WSI based prediction of TP53 mutations identifies aggressive disease phenotype in prostate cancer. In: CANCER RESEARCH. 2023.
- IEEE
- [1]M. Pizurica et al., “WSI based prediction of TP53 mutations identifies aggressive disease phenotype in prostate cancer,” in CANCER RESEARCH, Orlando, Florida, USA, 2023, vol. 83, no. 8, Supplement S.
@inproceedings{01HY0E617HN63BNTH94W375BVT, articleno = {{LB171}}, author = {{Pizurica, Marija and Larmuseau, Maarten and Van der Eecken, Kim and de Schaetzen van Brienen, Louise and Carrillo-Perez, Francisco and Isphording, Simon and Lumen, Nicolaas and Van Dorpe, Jo and Ost, Piet and Verbeke, Sofie and Gevaert, Olivier and Marchal, Kathleen}}, booktitle = {{CANCER RESEARCH}}, issn = {{0008-5472}}, language = {{eng}}, location = {{Orlando, Florida, USA}}, number = {{8, Supplement S}}, title = {{WSI based prediction of TP53 mutations identifies aggressive disease phenotype in prostate cancer}}, url = {{http://doi.org/10.1158/1538-7445.AM2023-LB171}}, volume = {{83}}, year = {{2023}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: